|
1
|
Lin QJ, Yang F, Jin C and Fu DL: Current
status and progress of pancreatic cancer in China. World J
Gastroenterol. 21:7988–8003. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeng Y: Advances in mechanism and
treatment strategy of cancer. Cell Mol Biol (Noisy-le-grand).
64:1–3. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
King J, Bouvet M, Singh G and Williams J:
Improving theranostics in pancreatic cancer. J Surg Oncol.
116:104–113. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang H, Feng X, Zhang M, Liu A, Tian L,
Bo W, Wang H and Hu Y: Long non-coding RNA CASC2 upregulates PTEN
to suppress pancreatic carcinoma cell metastasis by downregulating
miR-21. Cancer Cell Int. 19:182019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lian Y, Yang J, Lian Y, Xiao C, Hu X and
Xu H: DUXAP8, a pseudogene derived lncRNA, promotes growth of
pancreatic carcinoma cells by epigenetically silencing CDKN1A and
KLF2. Cancer Commun (Lond). 38:642018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li DS, Ainiwaer JL, Sheyhiding I, Zhang Z
and Zhang LW: Identification of key long non-coding RNAs as
competing endogenous RNAs for miRNA-mRNA in lung adenocarcinoma.
Eur Rev Med Pharmacol Sci. 20:2285–2295. 2016.PubMed/NCBI
|
|
8
|
Huang W, Su X, Yan W, Kong Z, Wang D,
Huang Y, Zhai Q, Zhang X, Wu H, Li Y, et al: Overexpression of
AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and
poor prognosis in prostate cancer. Prostate. 78:1248–1261. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qin Z, Zheng X and Fang Y: Long noncoding
RNA TMPO-AS1 promotes progression of non-small cell lung cancer
through regulating its natural antisense transcript TMPO. Biochem
Biophys Res Commun. 516:486–493. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui H and Zhao J: lncRNA TMPO-AS1 serves
as a ceRNA to promote osteosarcoma tumorigenesis by regulating
miR-199a-5p/WNT7B axis. J Cell Biochem. 121:2284–2293. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kartha RV and Subramanian S: Competing
endogenous RNAs (ceRNAs): New entrants to the intricacies of gene
regulation. Front Genet. 5:82014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Su QL, Zhao HJ, Song CF, Zhao S, Tian ZS
and Zhou JJ: MicroRNA-383 suppresses pancreatic carcinoma
development via inhibition of GAB1 expression. Eur Rev Med
Pharmacol Sci. 23:10729–10739. 2019.PubMed/NCBI
|
|
13
|
Pugongchai A, Bychkov A and Sampatanukul
P: Promoter hypermethylation of SOX11 correlates with adverse
clinicopathological features of human prostate cancer. Int J Exp
Pathol. 98:341–346. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang L, Yuan Z, Shi H, Bian Y and Guo R:
miR-145 targets the SOX11 3′UTR to suppress endometrial cancer
growth. Am J Cancer Res. 7:2305–2317. 2017.PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qi C, Xiaofeng C, Dongen L, Liang Y,
Liping X, Yue H and Jianshuai J: Long non-coding RNA MACC1-AS1
promoted pancreatic carcinoma progression through activation of
PAX8/NOTCH1 signaling pathway. J Exp Clin Cancer Res. 38:3442019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao L, Kong H, Sun H, Chen Z, Chen B and
Zhou M: lncRNA-PVT1 promotes pancreatic cancer cells proliferation
and migration through acting as a molecular sponge to regulate
miR-448. J Cell Physiol. 233:4044–4055. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang Y, Feng E, Sun L, Jin W, You Y, Yao
Y and Xu Y: An increased expression of long non-coding RNA PANDAR
promotes cell proliferation and inhibits cell apoptosis in
pancreatic ductal adenocarcinoma. Biomed Pharmacother. 95:685–691.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mohammadrezakhani H, Baradaran B,
Shanehbandi D, Asadi M, Hashemzadeh S, Hajiasgharzadeh K and
Safaralizadeh R: Overexpression and clinicopathological correlation
of long noncoding RNA TMPO-AS1 in colorectal cancer patients. J
Gastrointest Cancer. 51:952–956. 2019. View Article : Google Scholar
|
|
20
|
Wang Y, Fu J, Wang Z, Lv Z, Fan Z and Lei
T: Screening key lncRNAs for human lung adenocarcinoma based on
machine learning and weighted gene co-expression network analysis.
Cancer Biomark. 25:313–324. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang J, Liang B and Hou S: TMPO-AS1
promotes cervical cancer progression by upregulating RAB14 via
sponging miR-577. J Gene Med. 21:e31252019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu Y, Ma Y, Liu J, Cai Y, Zhang M and Fang
X: LINC01128 expedites cervical cancer progression by regulating
miR-383-5p/SFN axis. BMC Cancer. 19:11572019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shan T, Uyar DS, Wang LS, Mutch DG, Huang
TH, Rader JS, Sheng X and Huang YW: SOX11 hypermethylation as a
tumor biomarker in endometrial cancer. Biochimie. 162:8–14. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu B, Li J, Wang H, Wu Q and Liu H:
MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via
directly targeting SOX11. Naunyn Schmiedebergs Arch Pharmacol.
393:2197–2208. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang L, Shen YF, Shi ZM, Shang XJ, Jin DL
and Xi F: Overexpression miR-211-5p hinders the proliferation,
migration, and invasion of thyroid tumor cells by downregulating
SOX11. J Clin Lab Anal. 32:e222932018. View Article : Google Scholar
|
|
26
|
Wu Z, Huang W, Wang X, Wang T, Chen Y,
Chen B, Liu R, Bai P and Xing J: Circular RNA CEP128 acts as a
sponge of miR-145-5p in promoting the bladder cancer progression
via regulating SOX11. Mol Med. 24:402018. View Article : Google Scholar : PubMed/NCBI
|
